No Dox in the system. you could do this many times and still get no toxicity so how many cohorts needed before toxicity is found? it could run indefinitely and you effectively never find a maximum dose. trial part 1b would be delayed indefinitely so whats the plan?
Haven't heard much about the antimicrobial resistance testing. i think there could be alot of value in that. cancer success looks like a given in my opinion, but we have to wait til its ready to go. the AMR could be massive for revenues.
Does anyone have any ideas how much of this company is in the hands of private investors vs institutional investors would be interested to know and if it has anything to to with the current share price fall just curious perhaps its massively over priced at the moment who knows?
Any thoughts on what the business update and Q&A sesh might be at the AGM? can we expect some news coming in the next few weeks or is it a matter of going over the last years financials etc. im expecting a bit of clarity over the road map and path ahead and possibly some new aspect to the business such as a partnership or alliance of some sort.
I suspect this is something to do with boiler room tactics at play. if necessary you can always bring a flask or sneak in some supplies under cover - perhaps using an assay box which would allow plenty of room for insulation to keep flasks / cuppas hot. either way, its looking very interesting.
Indeed, if your holding, your exposed to down as well as upside. my feeling is were going to see an increase in value here in the not too distant future so any falls before then will ride out. if someone wants to risk selling / buying short term to make a bit extra then hats off to 'em, i might do the same if i saw the opportunity and had spare cash to fall back on.
Plenty of chunky trades going through, both buy and sell. seems the smarter investor (or "trader") is selling and picking up at a cheaper price. question is, how far could it fall, and is that a risky plan considering any new RNS could come out at any time that significantly lifts the value of the company.
There are plenty other stocks to make money more quickly on in my opinion. drumming up for investors looks a bit desperate. im not expecting anything to happen fast, investors seem to be jumping off like rats from a sinking ship.
i bought and sold this several times but you got to look at the long term. the likelihood of this venture succeeding is greater than it failing in my view. i think a buyout could be tricky but would look at selling if that came along. even with another cash raise i think it'll be difficult to hold back the price. be interesting to see what other commercial prospects come out of the woodwork in the coming weeks and months as that'll give a better indication of how things will progress.